Back to Journals » OncoTargets and Therapy » Volume 6

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Total article views   HTML views PDF downloads Totals
18,226 Dovepress* 11,443+ 2,078 13,521
PubMed Central* 6,783 1,465 8,248
Totals 18,226 3,543 21,769
*Since 14 February 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
17 1 0 0 3 13

View citations on PubMed Central and Google Scholar